Natural Capsules Q1FY27: Revenue Rs 48.71 Cr, PAT Loss Rs 5.74 Cr
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natural Capsules Q1FY27: Revenue Rs 48.71 Cr (down 17 percent QoQ, up 8 percent YoY). EBITDA rose to Rs 1.12 Cr with margins at 2.30 percent (up 251 percent YoY). PAT remained a loss of Rs 5.74 Cr on high finance costs. MD cited ERP transition disruption in last 5 days of quarter. Capsule margins held up via cost pass-throughs; firm converting HPMC lines to gelatine on erratic US demand. API arm commenced Fermbox Bio contract manufacturing and signed a new Mumbai client; first backward-integrated prednisolone batch expected by end of September.
Mixed signals - capsule margins improving but persistent PAT losses and elevated finance costs continue to weigh. API scaling and new CMO deals remain key monitorables.